O. Donnay
Hospital Universitario de La Princesa(ES)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Inflammatory Biomarkers in Disease Prognosis, Gastric Cancer Management and Outcomes, Colorectal Cancer Surgical Treatments
Most-Cited Works
- → Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients(2019)257 cited
- → SEOM clinical guidelines on nutrition in cancer patients (2018)(2019)111 cited
- → A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer(2019)79 cited
- → Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy(2018)60 cited
- → Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies(2020)35 cited
- → Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents(2019)31 cited
- → Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy(2015)26 cited
- → Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC(2022)14 cited
- → Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival(2018)9 cited
- → P2.02-027 Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?(2017)8 cited